Asymchem Laboratories (Tianjin) Co., Ltd. (FRA:7K90)

Market Cap	4.41B +18.7%
Revenue (ttm)	753.54M +12.8%
Net Income	124.37M +35.1%
EPS	0.34 +32.4%
Shares Out	n/a
PE Ratio	35.45
Forward PE	25.77
Dividend	0.13 (1.55%)
Ex-Dividend Date	Jun 25, 2025

Volume	n/a
Average Volume	n/a
Open	8.50
Previous Close	8.10
Day's Range	8.50 - 8.50
52-Week Range	4.50 - 12.30
Beta	n/a
RSI	52.42
Earnings Date	Mar 30, 2026

About FRA:7K90

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7K90

Financial Performance

In 2024, FRA:7K90's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY